Following our first post covering VentureSouth portfolio companies you can “meet” via their episodes on the Venture In The South podcast, here is batch #2, covering companies on episodes 134 to 200. Here in no particular (but reverse) order:
Adovate: Episode 184. Adovate is exploiting adenosine receptors involved in multiple major diseases with a drug candidate that has favorable physiochemical characteristics and distribution kinetics. CEO William Stilley explains the strategy of focusing on a single candidate that treats a common disease with few to no side effects, with a Phase II trial getting underway and a plan to sell the drug to a major pharma company if successful.
MP Cloud: Episode 181. MP Cloud provides Revenue Cycle Management for EMS providers. CEO Rob Rodrigues discusses how an industry acutely compressed by Medicaid cuts is a market opportunity for MP Cloud's tools to improve cash flow, streamline operations, and reduce errors in providers' everyday work.
Atticus Pharma: Episode 179. Atticus Pharma, a spinout of fellow portfolio company Zylo Therapeutics, is working to unlock the value of the Z-pod® topical delivery platform in the pharmaceutical vertical. CEO Leigh Hsu lays out the plan for the new venture.
Darby: Episode 176. Darby is a durable medical equipment marketplace platform disrupting legacy outpatient medical supply logistics that are still, remarkably, managed largely via fax. CEO Robin Smith walks through the opportunity.
MPath: Episode 172. MPath is a communication software that identifies individuals who need a preventive care service, provides them personalized education, and connects them to the care they need. Cofounder and CEO Dr. David Miller shares how the platform closes preventive-care gaps at scale.
Protect3D: Episode 169. Protect3D, a provider of custom-fabricated orthopedic devices using 3D technology, has grown over 100% year-over-year and counts more than 60 collegiate and professional sports teams as customers. CTO Tim Skapek discusses the company's next moves: expanding beyond athletics to serve orthopedic and general populations.
Yuva Biosciences: Episode 167. Yuva Biosciences is a longevity startup targeting mitochondrial science to address aging-related conditions, with topical solutions for hair loss and skin wrinkles built around its proprietary Y100 ingredient. Saksham Narang explains the licensing model behind Yuva's growing list of channel partners.
VBase Oil: Episode 159. VBase Oil is a B2B producer of new-tech proprietary synthetic ester base oils and lubricants that outperform traditional products while being bio-based, biodegradable, non-toxic, and non-bioaccumulating. Cofounders Jeff and Michelle DiMaio introduce the business in its first appearance on the show, not long after joining the VentureSouth portfolio.
CadChat: Episode 155. CadChat is a first-to-market meeting platform for 3D collaboration on product design, incorporating all major CAD platforms. CEO Graham Bredemeyer explains how it solves a big enterprise problem: bringing product design teams together in 3D space during meetings while preserving institutional memory of that collaboration.
Fashivly: Episode 151. Fashivly is an innovative online fashion platform with no inventory, multiple revenue streams, and profitability from a bootstrapped start, powered by a scalable AI model trained on its own proprietary data. Founder and CEO Ashlyn Greer describes the fully personalized, on-demand styling that's driving the platform's growth, with a men's offering on the way.
Scalable Systems: Episode 144. Scalable Systems Group (formerly WasteWizer) solves a weighty problem in industrial waste and recycling: knowing when a bin is full and ready to empty, across thousands of bins spread over hundreds of sites. Co-founder and Chief R&D Officer Thomas Spencer describes the proprietary, moving-parts-free weight-sensing technology and IoT network behind it, now expanding beyond metal recycling into other weight-driven industries.
That rounds out the portfolio companies featured up to episode 200. We hope you enjoyed the variety, and take home a lesson or two for your own entrepreneurial or investing efforts.